Cargando…

A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study

PURPOSE: This multicenter, prospective, observational study aimed to supplement real-world evidence on the effects of aclidinium bromide on the quality of life (QoL), symptoms, and activity impairment of patients with COPD. PATIENTS AND METHODS: Eligible patients were ≥40 years of age, newly initiat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostikas, Konstantinos, Vassilakopoulos, Theodoros I, Tzanakis, Nikos, Konstantinidis, Athanasios K, Kosmas, Epameinondas N, Papiris, Spyros, Steiropoulos, Paschalis, Manali, Effrosyni D, Michaelides, Stylianos A, Daskos, Grigorios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064283/ https://www.ncbi.nlm.nih.gov/pubmed/32184588 http://dx.doi.org/10.2147/COPD.S239044

Ejemplares similares

Association of the calcitriol to calcifediol ratio with cardiac involvement in newly diagnosed sarcoidosis
por: Gialafos, Elias, et al.
Publicado: (2020)

Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community
por: Tzanakis, Nikolaos, et al.
Publicado: (2022)

Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
por: Rivero-Ferrer, Elena, et al.
Publicado: (2022)

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease
por: Sims, Michael W, et al.
Publicado: (2011)

Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
por: Zhong, Jun, et al.
Publicado: (2014)

Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
por: Suppli Ulrik, Charlotte
Publicado: (2012)

Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
por: Jones, Paul W
Publicado: (2015)

Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on
por: Manali, Effrosyni D., et al.
Publicado: (2023)

Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD
por: Ramos, Mafalda, et al.
Publicado: (2016)

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler(®) Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study
por: Steiropoulos, Paschalis, et al.
Publicado: (2021)

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
por: Moitra, Subhabrata, et al.
Publicado: (2015)

Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study
por: Tzanakis, Nikolaos, et al.
Publicado: (2021)

Dual Bronchodilator in the Era of Triple Therapy
por: Papaioannou, Andriana I, et al.
Publicado: (2020)

Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomos, Ioannis, et al.
Publicado: (2021)

IPF-Acute Exacerbations: Advances and Future Perspectives
por: Papiris, Spyros A., et al.
Publicado: (2022)

Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years
por: Karabis, Andreas, et al.
Publicado: (2014)

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
por: D’Urzo, Anthony D., et al.
Publicado: (2019)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial
por: Wise, Robert A., et al.
Publicado: (2021)

Bench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivist
por: Papiris, Spyros A, et al.
Publicado: (2007)

Clinical review: Idiopathic pulmonary fibrosis acute exacerbations - unravelling Ariadne's thread
por: Papiris, Spyros A, et al.
Publicado: (2010)

Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients
por: Tselebis, Athanasios, et al.
Publicado: (2010)

Clinical benefit of two-times-per-day aclidinium bromide compared with once-a-day tiotropium bromide hydrate in COPD: a multicentre, open-label, randomised study
por: Kamei, Tadashi, et al.
Publicado: (2019)

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Papaioannou, Andriana I., et al.
Publicado: (2016)

Validation of NoSAS score for the screening of obstructive sleep apnea
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Clinical use of aclidinium in patients with COPD
por: Reid, Debra J, et al.
Publicado: (2014)

Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
por: D’Urzo, Anthony D, et al.
Publicado: (2014)

CD(8+ )T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis
por: Papiris, Spyros A, et al.
Publicado: (2007)

Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF
por: Triantafillidou, Christina, et al.
Publicado: (2011)

Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach
por: Papiris, Spyros A, et al.
Publicado: (2015)

Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
por: Wedzicha, Jadwiga A., et al.
Publicado: (2016)

The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants
por: Li, Weimin, et al.
Publicado: (2023)

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study
por: Manali, Effrosyni D, et al.
Publicado: (2010)

Massive hemoptysis in a patient with pulmonary embolism, a real therapeutic conundrum
por: Herodotou, Yiolanda, et al.
Publicado: (2017)

The 13 item Family Support Scale: Reliability and validity of the Greek translation in a sample of Greek health care professionals
por: Tselebis, Athanasios, et al.
Publicado: (2011)

Prevalence of lung function impairment among Greek cement production workers: a cross-sectional study
por: RACHIOTIS, George, et al.
Publicado: (2017)

Author Correction: Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study
por: Koulouris, Nikolaos, et al.
Publicado: (2022)

Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study
por: Koulouris, Nikolaos, et al.
Publicado: (2022)

Effect of Shift Work on Sleep, Health, and Quality of Life of Health-care Workers
por: Nena, Evangelia, et al.
Publicado: (2018)

Coexistent obstructive sleep apnea in patients with chronic obstructive pulmonary disease: Several unanswered questions need to be addressed
por: Voulgaris, Athanasios, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5sl6bpq7l8ilo978bjf53i1ul